Genmab A/S (GMAB) - 5i Research

Genmab A/S (GMAB $24.42)
- $24.42 P/E (TTM): 1.26X Cap: $15.92B
- View GMAB Profile
- View Questions on GMAB

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Genmab A/S (GMAB $24.42)
- $24.42 P/E (TTM): 1.26X Cap: $15.92B
- View GMAB Profile
- View Questions on GMAB

Q: Hello Team 5i,

I realize the Healthcare sector is having a tough time at the moment, but may I have your assessment of Genmab A/S's fundamentals please?

Thank you!

Read Answer Asked by Sandra on August 21, 2025